ADEPT Program for Diagnostic Errors
(ADEPT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to reduce diagnostic errors in hospitals by connecting different facilities to share data and improve diagnostic processes. Researchers seek to understand why diagnostic errors occur and find ways for hospitals, doctors, and patients to collaborate in preventing them. The study includes two groups: one will receive the usual care, while the other will participate in a new program called the ADEPT Program to improve diagnosis. The trial seeks adult patients admitted to a hospital's general medicine service who experienced serious incidents, such as late transfers to the ICU. As an unphased trial, this study offers patients the chance to contribute to groundbreaking research that could enhance diagnostic accuracy and patient safety across hospitals.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this program is safe for improving diagnostic processes?
Research has shown that the ADEPT Program is a real-world effort to enhance quality and safety in hospitals. It assists hospitals in identifying and correcting diagnostic errors. Specific safety data for this program does not exist because it is not a medical treatment but a tool for hospital use. The goal is to improve diagnostic accuracy and prevent errors that could harm patients. As the program focuses on refining hospital procedures rather than testing new drugs, typical safety concerns like side effects do not apply. The program encourages hospitals to learn from one another to improve patient diagnosis and treatment.12345
Why are researchers excited about this trial?
Researchers are excited about the ADEPT Program for Diagnostic Errors because it aims to tackle the persistent issue of diagnostic mistakes in hospitals. Unlike traditional methods that rely heavily on individual clinician judgment, the ADEPT Program introduces a systematic approach to improve diagnostic accuracy over a sustained period. By implementing this program, researchers hope to uncover strategies that could significantly reduce errors and enhance patient safety, which could lead to better outcomes across healthcare settings.
What evidence suggests that the ADEPT Program is effective for reducing diagnostic errors?
Research shows that the ADEPT Program, tested in this trial, aims to reduce diagnostic errors in hospitals. These errors occur frequently, with some studies showing error rates around 24%. The program improves how hospitals track and share diagnostic information. By doing so, hospitals can learn from each other and enhance accuracy. Early findings suggest that this approach helps hospitals identify and address common causes of these errors, leading to better patient care and fewer incorrect diagnoses.13467
Who Is on the Research Team?
Andrew Auerbach, MD, MPH
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for adult patients admitted to general medicine services at participating hospitals who either passed away during their stay, were moved to the ICU more than 48 hours after admission, or required rapid response intervention. It excludes those admitted for non-medical reasons or who were critically ill upon arrival.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-intervention (usual care)
Patients admitted to study hospitals in the 12 months prior to the start of the intervention
Intervention
Patients admitted to study hospitals during the 36 months of the intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- ADEPT Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brigham and Women's Hospital
Lead Sponsor
University of California, San Francisco
Collaborator
Agency for Healthcare Research and Quality (AHRQ)
Collaborator